- Home
- NARI vs BHC Comparison
NARI vs BHC Comparison
Compare NARI & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NARI
- BHC
- Stock Information
- Founded
- NARI 2011
- BHC N/A
- Country
- NARI United States
- BHC Canada
- Employees
- NARI N/A
- BHC N/A
- Industry
- NARI Medical/Dental Instruments
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- NARI Health Care
- BHC Health Care
- Exchange
- NARI Nasdaq
- BHC Nasdaq
- Market Cap
- NARI 3.0B
- BHC 3.0B
- IPO Year
- NARI 2020
- BHC N/A
- Fundamental
- Price
- NARI $49.66
- BHC $7.97
- Analyst Decision
- NARI Buy
- BHC Hold
- Analyst Count
- NARI 10
- BHC 4
- Target Price
- NARI $59.13
- BHC $7.25
- AVG Volume (30 Days)
- NARI 918.3K
- BHC 2.0M
- Earning Date
- NARI 10-28-2024
- BHC 10-30-2024
- Dividend Yield
- NARI N/A
- BHC N/A
- EPS Growth
- NARI N/A
- BHC N/A
- EPS
- NARI N/A
- BHC N/A
- Revenue
- NARI $574,498,000.00
- BHC $9,474,000,000.00
- Revenue This Year
- NARI $24.59
- BHC $9.59
- Revenue Next Year
- NARI $18.28
- BHC $3.53
- P/E Ratio
- NARI N/A
- BHC N/A
- Revenue Growth
- NARI 22.41
- BHC 10.91
- 52 Week Low
- NARI $36.73
- BHC $3.96
- 52 Week High
- NARI $67.13
- BHC $11.46
- Technical
- Relative Strength Index (RSI)
- NARI 53.46
- BHC 37.82
- Support Level
- NARI $47.96
- BHC $8.15
- Resistance Level
- NARI $52.59
- BHC $8.36
- Average True Range (ATR)
- NARI 2.13
- BHC 0.25
- MACD
- NARI -0.36
- BHC -0.18
- Stochastic Oscillator
- NARI 29.77
- BHC 0.27
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.